Calidi Biotherapeutics Stock Forward View - Price Action Indicator
| CLDI Stock | 0.83 0.03 3.49% |
Calidi Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Calidi Biotherapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 10th of February 2026 the rsi of Calidi Biotherapeutics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (1.56) | EPS Estimate Current Year (7.44) | EPS Estimate Next Year (5.52) | Wall Street Target Price 120.0048 | EPS Estimate Current Quarter (1.68) |
Using Calidi Biotherapeutics hype-based prediction, you can estimate the value of Calidi Biotherapeutics from the perspective of Calidi Biotherapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Calidi Biotherapeutics after-hype prediction price | USD 0.8 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Calidi Biotherapeutics to cross-verify your projections. Calidi Biotherapeutics Additional Predictive Modules
Most predictive techniques to examine Calidi price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Calidi using various technical indicators. When you analyze Calidi charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.03) | (0.04) |
| Check Calidi Biotherapeutics Volatility | Backtest Calidi Biotherapeutics | Information Ratio |
Calidi Biotherapeutics Trading Date Momentum
| On February 09 2026 Calidi Biotherapeutics was traded for 0.83 at the closing time. The top price for the day was 0.88 and the lowest listed price was 0.82 . The trading volume for the day was 41.5 K. The trading history from February 9, 2026 did not affect price variability. The overall trading delta against the current closing price is 2.41% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Calidi Biotherapeutics to competition |
Other Forecasting Options for Calidi Biotherapeutics
For every potential investor in Calidi, whether a beginner or expert, Calidi Biotherapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Calidi Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Calidi. Basic forecasting techniques help filter out the noise by identifying Calidi Biotherapeutics' price trends.Calidi Biotherapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Calidi Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Calidi Biotherapeutics could also be used in its relative valuation, which is a method of valuing Calidi Biotherapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Calidi Biotherapeutics Market Strength Events
Market strength indicators help investors to evaluate how Calidi Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Calidi Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Calidi Biotherapeutics stock market strength indicators, traders can identify Calidi Biotherapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 2827.64 | |||
| Daily Balance Of Power | (0.50) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 0.85 | |||
| Day Typical Price | 0.84 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.03) |
Calidi Biotherapeutics Risk Indicators
The analysis of Calidi Biotherapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Calidi Biotherapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting calidi stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.85 | |||
| Standard Deviation | 4.0 | |||
| Variance | 16.03 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Calidi Biotherapeutics
The number of cover stories for Calidi Biotherapeutics depends on current market conditions and Calidi Biotherapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Calidi Biotherapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Calidi Biotherapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Calidi Biotherapeutics Short Properties
Calidi Biotherapeutics' future price predictability will typically decrease when Calidi Biotherapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Calidi Biotherapeutics often depends not only on the future outlook of the potential Calidi Biotherapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Calidi Biotherapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 664.4 K | |
| Cash And Short Term Investments | 9.6 M |
Check out Historical Fundamental Analysis of Calidi Biotherapeutics to cross-verify your projections. For more detail on how to invest in Calidi Stock please use our How to Invest in Calidi Biotherapeutics guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is there potential for Biotechnology market expansion? Will Calidi introduce new products? Factors like these will boost the valuation of Calidi Biotherapeutics. Projected growth potential of Calidi fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Calidi Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Calidi Biotherapeutics requires distinguishing between market price and book value, where the latter reflects Calidi's accounting equity. The concept of intrinsic value - what Calidi Biotherapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Calidi Biotherapeutics' price substantially above or below its fundamental value.
It's important to distinguish between Calidi Biotherapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Calidi Biotherapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Calidi Biotherapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.